EIB Global Invests €2 Million in Vaccine Development at Akagera Medicines in Rwanda

(IN BRIEF) The European Investment Bank (EIB Global) has committed €2 million to support Akagera Medicines Africa Limited in Rwanda, facilitating the early-stage development of vaccines for infectious diseases, including tuberculosis, HIV, Ebola, and Lassa fever. This funding aims to … Read the full press release →